Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Beule, Dieter Dr. (1) Daniel, Peter Prof. Dr. (1) Henssen, Anton Prof. Dr. med. (1) Höpken, Uta Elisabeth PD Dr. (1) Kammertöns, Thomas Dr. (1) Kopp, Joachim Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (2) Na, Il-Kang Dr. (1) Obermayer-Wasserscheid, Benedikt Dr. (1) Pezzutto, Antonio Prof. Dr. (2) Siffrin, Volker (1) Uckert, Wolfgang Prof. Dr. (2) Walther, Wolfgang Prof. Dr. (1) Willimsky, Gerald Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (15) Bioinformatics and Omics Data Science (1) Biologie maligner Lymphome (8) Entwicklung Mechanismus-basierter Krebstherapien (1) Immundysregulationen in der Onkologie (1) Mikroumgebung als Regulator bei Autoimmunität und Krebs (1) (-) Molekulare Immunologie und Gentherapie (15) Systembiologie von Gen-regulatorischen Elementen (2) Translational Bioinformatics (1) 1992 (4) 1993 (7) 1994 (5) (-) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (8) 2005 (10) 2006 (1) 2007 (5) 2008 (5) 2009 (2) 2010 (7) 2011 (5) 2012 (6) 2013 (11) 2014 (3) (-) 2015 (3) 2016 (4) 2017 (6) 2018 (5) 2019 (6) (-) 2021 (4) 2022 (6) 2023 (4) 2024 (2) 15 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Molekulare Immunologie und Gentherapie 199520152021 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Januar 1995 / Cytokine The rat interleukin-4 receptor: coevolution of ligand and receptor G. Richter G. Hein T. Blankenstein T. Diamantstein 01. Januar 1995 / Blood Human lymphotoxin has at least equal antitumor activity in comparison to human tumor necrosis factor but is less toxic in mice Z. Qin L.J.H. van Tits W.A. Buurman T. Blankenstein 01. Januar 1995 / J Immunol IL-10 converts mouse lymphoma cells to a CTL-resistant, nk-sensitive phenotype with low but peptide-inducible MHC class I expression F. Salazar-Onfray M. Petersson L. Franksson M. Matsuda T. Blankenstein K. Karre R. Kiessling 01. Januar 1995 / Eur J Immunol Tumor cells cotransfected with interleukin-7 and B7.1 genes induce CD25 and CD28 on tumor-infiltrating T lymphocytes and are strong vaccines S. Cayeux C. Beck A. Aicher B. Doerken T. Blankenstein 01. Januar 1995 / Eur J Cancer European school of oncology position paper - gene therapy for the medical oncologist M. Blaese T. Blankenstein M. Brenner O. Cohenhaguenauer B. Gansbacher B. Sorrentino T. Velu 01. Januar 1995 / Hum Gene Ther The thymidine kinase/ganciclovir-mediated "suicide" effect is highly variable in different tumor cells C. Beck S. Cayeux S. Lupton B. Doerken T. Blankenstein 01. Januar 1995 / Canc Res Tumor growth inhibition mediated by lymphotoxin: evidence of B lymphocyte involvement in the antitumor response Z. Qin T. Blankenstein 01. Januar 1995 / Canc Gene Ther Vectors in cancer therapy: how will they deliver M. Blaese T. Blankenstein M. Brenner O. Cohen-Haguenauer B. Gansbacher S. Russell B. Sorrentino T. Velu 15. Juni 2021 / Int J Cancer Long-term in vitro expansion ensures increased yield of central memory T cells as perspective for manufacturing challenges S. Herda A. Heimann B. Obermayer E. Ciraolo S. Althoff J. Ruß C. Grunert A. Busse L. Bullinger A. Pezzutto T. Blankenstein D. Beule I.K. Na 15. April 2015 / Int J Cancer Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB A. Flörcken M. Grau A. Wolf A. Weilemann J. Kopp B. Dörken T. Blankenstein A. Pezzutto P. Lenz G. Lenz J. Westermann Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. Januar 1995 / Cytokine The rat interleukin-4 receptor: coevolution of ligand and receptor G. Richter G. Hein T. Blankenstein T. Diamantstein
01. Januar 1995 / Blood Human lymphotoxin has at least equal antitumor activity in comparison to human tumor necrosis factor but is less toxic in mice Z. Qin L.J.H. van Tits W.A. Buurman T. Blankenstein
01. Januar 1995 / J Immunol IL-10 converts mouse lymphoma cells to a CTL-resistant, nk-sensitive phenotype with low but peptide-inducible MHC class I expression F. Salazar-Onfray M. Petersson L. Franksson M. Matsuda T. Blankenstein K. Karre R. Kiessling
01. Januar 1995 / Eur J Immunol Tumor cells cotransfected with interleukin-7 and B7.1 genes induce CD25 and CD28 on tumor-infiltrating T lymphocytes and are strong vaccines S. Cayeux C. Beck A. Aicher B. Doerken T. Blankenstein
01. Januar 1995 / Eur J Cancer European school of oncology position paper - gene therapy for the medical oncologist M. Blaese T. Blankenstein M. Brenner O. Cohenhaguenauer B. Gansbacher B. Sorrentino T. Velu
01. Januar 1995 / Hum Gene Ther The thymidine kinase/ganciclovir-mediated "suicide" effect is highly variable in different tumor cells C. Beck S. Cayeux S. Lupton B. Doerken T. Blankenstein
01. Januar 1995 / Canc Res Tumor growth inhibition mediated by lymphotoxin: evidence of B lymphocyte involvement in the antitumor response Z. Qin T. Blankenstein
01. Januar 1995 / Canc Gene Ther Vectors in cancer therapy: how will they deliver M. Blaese T. Blankenstein M. Brenner O. Cohen-Haguenauer B. Gansbacher S. Russell B. Sorrentino T. Velu
15. Juni 2021 / Int J Cancer Long-term in vitro expansion ensures increased yield of central memory T cells as perspective for manufacturing challenges S. Herda A. Heimann B. Obermayer E. Ciraolo S. Althoff J. Ruß C. Grunert A. Busse L. Bullinger A. Pezzutto T. Blankenstein D. Beule I.K. Na
15. April 2015 / Int J Cancer Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB A. Flörcken M. Grau A. Wolf A. Weilemann J. Kopp B. Dörken T. Blankenstein A. Pezzutto P. Lenz G. Lenz J. Westermann